TrialJournal of gastroenterology2016

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study.

Norio Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.